Seroprevalencia e infección por parvovirus humano B19 en embarazadas de Córdoba, Argentina, 2021-2022
in the population studied, B19V seroprevalence for was 67.5% and independent of the predictive factors, leaving 32.5% without evidence of exposure to the virus (susceptible to contracting the infection in the future). The detection of infection in symptomatic cases indicates the importance of investigating B19V in this group.
Authors
- Edgar Ortíz (ORCID: https://orcid.org/0000-0001-8625-659X)
- Gabriel Amilcar Boggio (ORCID: https://orcid.org/0000-0001-9290-9307)
- María Belén Colazo Salbetti (ORCID: https://orcid.org/0000-0002-5308-1102)
- Alicia González
- María Pilar Adamo (ORCID: https://orcid.org/0000-0002-3639-3323)
- Hector Dante Lucchini
- Nicolás Lionel Olivera (ORCID: https://orcid.org/0009-0001-6132-3773)
- Néstor Dicuatro
- Mauro Pedranti (ORCID: https://orcid.org/0000-0003-4884-1370)
- Laura Moreno (ORCID: https://orcid.org/0000-0003-4006-2305)
- Carlos Resino
Institutions
- Universidad Nacional de Córdoba (AR)
Publication Details
- Journal
- Revista de la Facultad de Ciencias Médicas de Córdoba
- Published
- 2024-12-13
- DOI
- https://doi.org/10.31053/1853.0605.v81.n4.44771
- Primary Topic
- Parvovirus B19 Infection Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00